Amgen Inc (AMGN) has declared a quarterly dividend of $2.38 per share, payable to shareholders of record. The ex-dividend date is set for November 20, 2025, meaning investors must own shares before this date to qualify for the dividend. Eligible shareholders will receive the payment on December 11, 2025.
This dividend reflects a yield of 2.97%, calculated based on the current stock price. Amgen, a leading biotechnology company headquartered in Thousand Oaks, California, focuses on developing human therapeutics for high unmet medical needs. The company currently has a market capitalization of $169.9 billion, a P/E ratio of 24.26, and an EPS of 12.94.
Such decisions highlight Amgen's commitment to providing regular income to its shareholders. The company’s dividend history and current payout ratio are essential metrics for investors assessing the sustainability of these payments.
Amgen's upcoming earnings report is scheduled for August 2, 2026, with an estimated EPS of $5.71 and projected revenue of $9.4 billion. This update provides insight into the company's ongoing financial health and operational performance.